Memorial Sloan Kettering Cancer Center – Prostate Cancer

Access Program Information

The purpose of this study is to use a new imaging drug called 11C-choline that is used with
a PET/CT scan to see prostate cancer when it cannot be seen well on other scans, such as
bone scans, CT or MRI.

Rare Disease: